Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye
- PMID: 30809471
- PMCID: PMC6376227
- DOI: 10.18240/ijo.2019.02.01
Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye
Abstract
Aim: To observe the effect of topical 0.05% cyclosporine A (CsA) on the ocular surface and tear protein lacritin in a botulinum B-induced dry eye rat model.
Methods: A total of 36 female SD rats were randomly divided into 3 groups, botulinum B was injected into the right lacrimal gland of all rats. Group A and group B were treated with 0.05% CsA and 0.1% sodium hyaluronate, respectively, 3 times daily. The control group was not treated. Basal tear flow, corneal epithelial defects, and lacritin levels were measured.
Results: Tear secretion in all rats was reduced on day 3 and was even lower on day 7 postoperation (P<0.05). Tear secretion in group A increased by day 14 and was at the preoperative level on day 42. Tear secretion in group B and control rats was lower on days 14 and 42 compared with preoperative level (P<0.05). Corneal fluorescein staining in group A was higher on day 3, peaked on day 7, and then decreased gradually from day 7 until day 14, returning to normal by day 42 post-procedure. However, in group B, corneal fluorescein staining had improved, but was not fully recovered by day 42. Corneal fluorescein staining was more intense than before the operation and then in the control group at all time points. Tear protein lacritin levels reached the lowest levels on day 7 in all groups. In group A, tear protein lacritin levels began to increase on day 14 and were normal on day 42. In group B, tear protein lacritin levels began to increase on day 14, but had not completely recovered on day 42. In the control group, tear protein lacritin levels remained low post-procedure.
Conclusion: CsA 0.05% prompts tear protein lacritin expression in a rat model of dry eye and improves the signs and symptoms of dry eye disease.
Keywords: 0.05% cyclosporine A; dry eye; tear protein lacritin.
Figures
Similar articles
-
Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.J Ocul Pharmacol Ther. 2018 Nov;34(9):633-641. doi: 10.1089/jop.2018.0044. Epub 2018 Sep 18. J Ocul Pharmacol Ther. 2018. PMID: 30227093
-
Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated.Invest Ophthalmol Vis Sci. 2011 Aug 5;52(9):6265-70. doi: 10.1167/iovs.10-6220. Invest Ophthalmol Vis Sci. 2011. PMID: 21087963 Free PMC article.
-
Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.Invest Ophthalmol Vis Sci. 2014 Jul 17;55(8):5401-9. doi: 10.1167/iovs.14-13924. Invest Ophthalmol Vis Sci. 2014. PMID: 25034600 Free PMC article.
-
Lacritin and the tear proteome as natural replacement therapy for dry eye.Exp Eye Res. 2013 Dec;117:39-52. doi: 10.1016/j.exer.2013.05.020. Epub 2013 Jun 12. Exp Eye Res. 2013. PMID: 23769845 Free PMC article. Review.
-
Lacritin and other new proteins of the lacrimal functional unit.Exp Eye Res. 2009 May;88(5):848-58. doi: 10.1016/j.exer.2008.09.002. Epub 2008 Sep 18. Exp Eye Res. 2009. PMID: 18840430 Free PMC article. Review.
Cited by
-
The Role of Endogenous Antimicrobial Peptides in Modulating Innate Immunity of the Ocular Surface in Dry Eye Diseases.Int J Mol Sci. 2021 Jan 13;22(2):721. doi: 10.3390/ijms22020721. Int J Mol Sci. 2021. PMID: 33450870 Free PMC article. Review.
-
Animal models of dry eye disease: Useful, varied and evolving (Review).Exp Ther Med. 2021 Dec;22(6):1394. doi: 10.3892/etm.2021.10830. Epub 2021 Oct 1. Exp Ther Med. 2021. PMID: 34650642 Free PMC article. Review.
-
[Effect of topical injection of cyclosporine A on saliva secretion and inflammation in the submandibular gland of non-obese diabetic mice].Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Aug 18;53(4):750-757. doi: 10.19723/j.issn.1671-167X.2021.04.022. Beijing Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34393240 Free PMC article. Chinese.
References
-
- Moss SE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264. - PubMed
LinkOut - more resources
Full Text Sources